A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.

Biologic effects of androgen on target cells are mediated in part by transcriptional regulation of androgen-regulated genes (ARGs) by androgen receptor. Using serial analysis of gene expression (SAGE), we have identified a comprehensive repertoire of ARGs in LNCaP cells. One of the SAGE-derived tags exhibiting homology to an expressed sequence tag was maximally induced in response to synthetic androgen R1881 treatment. The open reading frame of the androgen-induced RNA (PMEPA1) was characterized as a 759-bp nucleotide sequence coding for a 252-amino-acid protein. The analysis of PMEPA1 protein sequence indicated the existence of a type Ib transmembrane domain between residues 9 and 25. Analysis of multiple-tissue Northern blots revealed the highest level of PMEPA1 expression in prostate tissue. PMEPA1 expression was predominately detected in glandular epithelial cells of prostate by in situ hybridization analysis. The expression of PMEPA1 in LNCaP cells was induced by androgen in a time- and dose-specific manner. Evaluation of PMEPA1 expression in androgen-dependent/independent tumors of the CWR22 xenograft model revealed that PMEPA1 was overexpressed in three of four androgen-independent tumor tissues. These observations define PMEPA1 as a novel androgen-regulated gene exhibiting abundant expression in prostate tissue. The increased expression of PMEPA1 in relapsed tumors of the CWR22 model suggests activation of androgen signaling in hormone refractory disease. PMEPA1, along with other highly androgen-induced prostate-specific genes, has potential to serve as an androgen signaling read-out biomarker in prostate tissue.

[1]  B Johansson,et al.  Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer , 1997, Genes, chromosomes & cancer.

[2]  D. Pinkel,et al.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. , 1998, Cancer research.

[3]  D. Tindall,et al.  Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.

[4]  J. Veldscholte,et al.  Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. , 1997, Cancer research.

[5]  J. Trapman,et al.  Androgen-regulated gene expression in prostate cancer. , 1997, Seminars in cancer biology.

[6]  W. Tilley,et al.  Androgen receptors in prostate cancer. , 1996, The Journal of endocrinology.

[7]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[8]  L. Hood,et al.  Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. , 1999, Cancer research.

[9]  J. Moul.  Contemporary hormonal management of advanced prostate cancer. , 1998, Oncology.

[10]  S. Schwartz,et al.  CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. , 1996, Cancer research.

[11]  J. Swinnen,et al.  Identification of the Phosphatidic Acid Phosphatase Type 2a Isozyme as an Androgen-regulated Gene in the Human Prostatic Adenocarcinoma Cell Line LNCaP* , 1998, The Journal of Biological Chemistry.

[12]  C. Reznikoff,et al.  Dominant genetic alterations in immortalization: Role for 20q gain , 1999, Genes, chromosomes & cancer.

[13]  D. E. Henson,et al.  Molecular Pathology of Early Cancer , 1999 .

[14]  X. Cai,et al.  Genes regulated by androgen in the rat ventral prostate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Visakorpi,et al.  Androgen receptor gene and hormonal therapy failure of prostate cancer. , 1998, The American journal of pathology.

[16]  M. Newton,et al.  p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. , 1999, Cancer research.

[17]  Ankita Patel,et al.  Frequency and pattern of karyotypic abnormalities in human prostate cancer. , 1990, Cancer research.

[18]  Desok Kim,et al.  Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.

[19]  P. Meltzer,et al.  Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.

[20]  H. Moch,et al.  Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. , 1998, The American journal of pathology.

[21]  R S Warren,et al.  Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization , 1999, Genes, chromosomes & cancer.

[22]  A. Shabsigh,et al.  Fas antigen/CD‐95 upregulation and activation during castration‐induced regression of the rat ventral prostate gland , 1999 .

[23]  G. Jenster,et al.  The role of the androgen receptor in the development and progression of prostate cancer. , 1999, Seminars in oncology.

[24]  S. Detera-Wadleigh,et al.  Multiple transcriptional variants and RNA editing in C18orf1, a novel gene with LDLRA and transmembrane domains on 18p11.2. , 1998, Genomics.

[25]  G. Stamp,et al.  Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. , 1999, The American journal of pathology.